Contura at ACVS 2025

This year’s ACVS Surgery Summit, taking place October 23–25, is one of the veterinary industry’s most influential forums, uniting surgeons, specialists, and researchers dedicated to advancing clinical excellence. The program highlights the latest innovations in orthopedics, sports medicine, and regenerative therapies, shaping the future of patient care across both small and large animals.

This year’s ACVS program features new Arthramid® data and translational insights that will directly shape the future of joint health across species.

• See the latest data first: including new 0–84 day canine elbow OA results and equine osteoarthritis model findings.
• Hear directly from leading experts like Dr. Matthew Brunke and Dr. Lisa Fortier as they present cutting-edge research.
• Discover translational insights across the One Health continuum, linking human and veterinary joint care.
• Stay ahead in orthopedics and regenerative medicine with evidence that’s reshaping treatment approaches for dogs, horses, and beyond.

Presentations & Posters

2.5% Polyacrylamide Gel in Canine Elbow OA (0–84 Day Data)  
Speaker: Matthew Brunke DVM, DAVSMR, CCAT
When: Friday, October 24, poster

Owner-Reported Outcomes Indicate Intra-Articular 2.5% Polyacrylamide Hydrogel (2.5% iPAAG) Injection is Well-Tolerated and Reduces Osteoarthritis Signs in Dogs 
Speaker: Matthew Brunke DVM, DAVSMR, CCAT
When: Friday, October 24, poster

2.5% Hydrogel in an Equine Osteoarthritis Model 
Speaker: Katie Seabaugh DVM, DACVS, DACVSMR
When: Friday, October 24 poster

Arthramid and the One Health Continuum: Translational Insights in Synovitis and Osteoarthritis 
Speakers: Matthew Brunke DVM, DAVSMR, CCAT and Lisa Fortier DVM, PhD, ACVS
When: Saturday, October 25 at 12:15 EST podium